Medicare Enrolled
Dr. Mohannad Bisharat, M.D.
Internal Medicine · Pampa, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bisharat from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bisharat? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bisharat
Dr. Mohannad Bisharat is an internal medicine in Pampa, TX, with 16 years in practice. Based on federal Medicare data, Dr. Bisharat performed 3,450 Medicare services across 2,138 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bisharat received a total of $179,359 from 62 pharmaceutical and/or device companies across 932 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bisharat is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice▲ Top 10% volume in TX$ $179,359 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,450
Medicare services
Top 10% in TX for internal medicine
2,138
Unique beneficiaries
$384
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~216 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 410 | $95 | $270 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 292 | $9 | $105 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 288 | $137 | $640 |
| Regadenoson injection (Lexiscan) for heart stress test | 258 | $44 | $100 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 196 | $138 | $471 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 190 | $39 | $150 |
| Ultrasonic guidance for blood vessel access | 178 | $31 | $90 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 137 | $141 | $486 |
| Electrocardiogram (EKG), 12-lead | 127 | $11 | $43 |
| Ultrasound of leg arteries or artery grafts | 110 | $177 | $770 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 108 | $308 | $950 |
| Ultrasound of both sides of head and neck blood flow | 93 | $139 | $498 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 87 | $739 | $4,010 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 66 | $53 | $189 |
| Removal of plaque in artery of leg, initial vessel | 58 | $5,970 | $30,000 |
| Nuclear medicine study of heart muscle blood flow by pet | 54 | $139 | $744 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 53 | $2,092 | $6,000 |
| Review by radiologist of abdominal aorta image | 52 | $101 | $425 |
| Hospital follow-up visit, high complexity | 47 | $96 | $265 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 46 | $77 | $805 |
| Review by radiologist of major lower body vein image | 45 | $88 | $450 |
| Coronary stent placement | 44 | $417 | $12,000 |
| Cardiac catheterization | 43 | $705 | $3,650 |
| Removal of plaque in arteries of leg | 42 | $3,810 | $26,500 |
| Review by radiologist of both arms or legs arteries image | 38 | $130 | $608 |
| Review by radiologist of both arms and legs veins of both arms or legs image | 31 | $106 | $400 |
| Insertion of tube into vein, second order branch | 30 | $481 | $2,525 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 29 | $195 | $694 |
| Insertion of stent in vein with review by radiologist, initial vein | 28 | $2,679 | $12,190 |
| Review by radiologist of arm or leg artery image | 28 | $121 | $435 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 27 | $93 | $299 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 26 | $62 | $210 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 24 | $90 | $150 |
| Removal of plaque and insertion of stents in arteries of leg | 23 | $8,522 | $42,500 |
| Removal and dissolving of blood clot from vein using fluoroscopic guidance, initial treatment | 20 | $314 | $6,000 |
| Office visit, established patient (20-29 min) | 19 | $64 | $181 |
| Insertion of tube into vena cava | 18 | $248 | $1,435 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 17 | $84 | $360 |
| Balloon dilation of artery of leg, each additional vessel | 15 | $648 | $3,500 |
| Initial hospital admission, moderate complexity | 15 | $101 | $349 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 13 | $549 | $1,832 |
| New patient office visit (45-59 min) | 13 | $126 | $416 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 12 | $340 | $1,192 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.1% high complexity
37.3% medium
52.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$179,359
Total received (2018-2024)
Avg $25,623/year across 7 years
Top 1% in TX for internal medicine
62
Companies
932
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$90,686 (50.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$64,456 (35.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,217 (13.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$46,704
2023$48,036
2022$39,834
2021$34,032
2020$5,164
2019$3,871
2018$1,719
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Inari Medical, Inc.
$110,319
Bard Peripheral Vascular, Inc.
$17,403
Abbott Laboratories
$15,593
Cardiovascular Systems Inc.
$7,356
Wilson Cook Medical Incorporated
$4,635
ABIOMED
$3,793
AngioDynamics, Inc.
$3,088
Medtronic, Inc.
$2,542
Penumbra, Inc.
$1,865
ARGON MEDICAL DEVICES, INC.
$1,735
Amgen Inc.
$1,383
Boston Scientific Corporation
$1,294
Cook Medical LLC
$710
Philips Electronics North America Corporation
$629
Philips North America LLC
$537
Janssen Pharmaceuticals, Inc
$427
CVRx, Inc.
$379
Impulse Dynamics (USA) Inc.
$374
PFIZER INC.
$323
Novartis Pharmaceuticals Corporation
$301
Venclose Inc.
$299
ShockWave Medical, Inc
$265
Amarin Pharma Inc.
$254
SANOFI-AVENTIS U.S. LLC
$227
AstraZeneca Pharmaceuticals LP
$225
Medtronic Vascular, Inc.
$220
Reflow Medical Inc
$209
Boehringer Ingelheim Pharmaceuticals, Inc.
$208
Terumo Medical Corporation
$201
E.R. Squibb & Sons, L.L.C.
$195
Cardiac Assist, Inc.
$173
Imperative Care, Inc
$142
BOSTON SCIENTIFIC CORPORATION
$138
Baxter Healthcare
$130
Bardy Diagnostics, Inc.
$128
Actelion Pharmaceuticals US, Inc.
$126
HeartFlow, Inc.
$124
Contego Medical, Inc
$120
Surmodics, Inc.
$116
Merck Sharp & Dohme LLC
$116
Avinger Inc.
$116
Edwards Lifesciences Corporation
$105
ASAHI INTECC USA, INC.
$100
Teleflex LLC
$94
CeloNova BioSciences, Inc.
$93
SCPHARMACEUTICALS INC.
$75
Cardinal Health 200, LLC
$65
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$46
Kiniksa Pharmaceuticals International, plc
$44
Astellas Pharma US Inc
$43
W. L. Gore & Associates, Inc.
$36
Shockwave Medical, Inc
$35
Siemens Medical Solutions USA, Inc.
$27
Relypsa, Inc.
$26
Novo Nordisk Inc
$26
Merck Sharp & Dohme Corporation
$25
Esperion Therapeutics, Inc.
$21
Kiniksa Pharmaceuticals, Ltd.
$21
Alnylam Pharmaceuticals Inc.
$16
ATRICURE, INC.
$15
Kowa Pharmaceuticals America, Inc.
$13
ZOLL Circulation Inc
$13
Top 3 companies account for 79.9% of total payments
Associated products mentioned in payments ›
(4066) Tack Endovascular Systems ATK · (4067) Tack Endovascular Systems BTK · (6536) Phoenix · (6582) Visions 035 · (888) PV 018 OTW · (9260) QC · (AZ7) Lasers · (BR5) Peripheral IVUS · (BS1) Peripheral Vascular Undivided · (CK4) MCOT · (DD3) Venous Stent Und · ABRE · ADVANCE · ALPHAVAC · AMPLATZ · ASAHI PTCA Guide Wire · AURYON LASER SYSTEM 100-120 VAC · Arcalyst · Artis Q.zen · Atlas · Auryon Laser System 100-120 Vac · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHOCOLATE PTA BALLOON CATHETER · COREVALVE EVOLUT R · CT THROMBECTOMY SYSTEM KIT · Carnation Ambulatory Monitor · Cleaner · Corlanor · Crosser iQ · DIAMONDBACK CORONARY · DIAMONDBACK PERIPHERAL · Diamondback Coronary · Diamondback Peripheral · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM · ENTRESTO · ESPRIT · EVRSF · EkoSonic · FARXIGA · FFRct · FLEXOR · FLOWTRIEVER CATHETER · FUROSCIX · FlowTriever · Fluency Endovascular Stent Graft · GENERAL ATHERECTOMY · GENERAL VASCULAR INTERVENTION · GENERAL ANGIOPLASTY · GENERAL ATHERECTOMY · GENERAL VASCULAR INTERVENTION · GENERAL - ATHERECTOMY · GENERAL - THROMBECTOMY · GENERAL - VASCULAR INTERVENTION · GENERAL VASCULAR INTERVENTION · GLIDESHEATH SLENDER · GORE VIABAHN VBX Balloon Expandable Endo · General - Angioplasty · General - Atherectomy · General - Thrombectomy · General - Vascular Intervention · HAWKONE · HawkOne · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · IGT D Peripheral · IGT_D Peripheral · IN.PACT ADMIRAL · IN.PACT Admiral · Impella · Indigo · Indigo System · JARDIANCE · JETI · LEQVIO · LEXISCAN · LOKELMA · LifeStream · LifeVest · Livalo · MANTA · MITRACLIP · MULTAQ · MYNX CONTROLTM · Mitra Clip system · MitraClip System · NEXLETOL · ONPATTRO · ONYX FRONTIER · OPSUMIT · OPTIMIZER · OPTIS · Optimizer · Optis Coronary Imaging System · PANTHERIS · PRALUENT · PRODIGY CATHETER · Penumbra System · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · R2P MISAGO · ROSEN · RUBY Coil · Repatha · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYMPHONY CATHETER · SYNERGY ABLATION SYSTEM · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Sublime 014 Rx PTA Balloon Dilatation Catheter · THROMBECTOMY · TURBOHAWK · TandemHeart · TherOx DS2 Console · Trilogy 100 · UPTRAVI · VENASEAL · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · Veltassa · VenaSeal · Venclose Maven Catheter · Venovo · Viance · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZILVER PTX · ZILVER VENA · Zilver Vena
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (51%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for internal medicine in TX.
Equivalent to $5,199 per 100 Medicare services performed
Geographic Context
Internal Medicines within 10 mi
6
Per 100K population
28.4
County median income
$56,082
Nearest hospital
PAMPA REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bisharat is a clinical cardiology specialist, with above-average Medicare volume (top 10% in TX), and high industry engagement (consulting-driven, top 1%), with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bisharat experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bisharat performed 410 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bisharat receive payments from pharmaceutical companies?
Yes. Dr. Bisharat received a total of $179,359 from 62 companies across 932 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bisharat's costs compare to other internal medicines in Pampa?
Dr. Bisharat's average Medicare payment per service is $384. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bisharat) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicines in Pampa
Browse internal medicines in Pampa ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicines in TX
Internal Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicines in TX
Which TX internal medicines receive the most from drug and device companies.
By company
Inari Medical, Inc. Payments to Doctors
See all physicians who received payments from Inari Medical, Inc..
By company
Bard Peripheral Vascular, Inc. Payments to Doctors
See all physicians who received payments from Bard Peripheral Vascular, Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology